Biotech & pharma
Straight from the gut: Microbes can cause obesity
By By Helen Dodson | 04 Feb 2012
Research proves plausibility of new primordial pathway to life’s chemical building blocks
02 Feb 2012
Metabolic errors can spell doom for DNA
By By Anne Trafton, MIT News Office | 01 Feb 2012
Many critical cell functions depend on a class of molecules called purines, which form half of the building blocks of DNA and RNA, and are a major component of the chemicals that store a cell’s energy. MIT biological engineers have precisely measured the effects of errors in systems for purine production and breakdown
Genetic breakthrough for brain cancer in children
31 Jan 2012
Research team identifies two mutations in crucial gene involved in deadly paediatric brain tumours
Researchers induce Alzheimer’s neurons from pluripotent stem cells
By By Scott LaFee | 27 Jan 2012
For the first time scientists have created stem cell-derived, in vitro models of sporadic and hereditary Alzheimer’s, using induced pluripotent stem cells from patients with the neurodegenerative disorder
Scientists link evolved, mutated gene module to syndromic autism
By By Debra Kain, Scott LaFee | 27 Jan 2012
Viruses con bacteria into working for them
27 Jan 2012
Scripps researchers illuminate cancer cells’ survival strategy during dangerous dissemination
27 Jan 2012
Envelope for an artificial cell
25 Jan 2012
How cells dispose of their waste
24 Jan 2012
Scientists create novel RNA repair technology
18 Jan 2012
Tiny worm points to big promise
13 Jan 2012
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
